OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Diabetic Metabolic Decompensation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,367 reports · 36 co-occurring drugs

As of the last recalculation, Diabetic Metabolic Decompensation appears in 1,367 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is INSULIN GLARGINE-YFGN (PRR 112.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Insulin Glargine-Yfgn145112.8113.6
Insulin Glulisine4264.965.1
Insulin Degludec4932.933.0
Dapagliflozin6331.932.0
Glimepiride7430.530.6
Metformin46929.930.0
Metformin Hydrochloride Tablets10128.928.9
Metformin Hydrochloride Extended-Release Tablets10128.928.9
Metformin Hydrochloride Tablet10128.928.9
Metformin Hydrochloride10228.328.3
Sitagliptin And Metformin Hydrochloride3726.826.9
Metformin Er 500 Mg36825.125.1
Metformin Er 750 Mg36825.125.1
Insulin Glargine30023.423.5
Empagliflozin8019.219.2
Pioglitazone5219.019.0
Indapamide2219.019.0
Alpelisib915.815.8
Insulin5415.315.3
Fenofibrate3414.915.0
Liraglutide4514.314.3
Insulin Aspart5914.214.2
Insulin Human3312.912.9
Dulaglutide6712.012.1
Linagliptin1411.811.8
Fosaprepitant Dimeglumine1011.111.2
Sitagliptin4910.710.7
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose59.39.3
Insulin Lispro768.88.8
Aprepitant108.38.3
Sorafenib118.18.1
Baricitinib57.97.9
Encorafenib46.26.2
Ipilimumab145.05.0
Exenatide144.14.1
Aflibercept73.43.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.